MOH · Molina Healthcare Q2 FY2026 earnings call record财报电话会记录

“We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC, as well as our risk factors listed in our Form 10-Q and Form 8-K filings with the SEC.”

“Last night, we reported adjusted earnings per share of $1.51 on $10.2 billion of premium revenue.”

“We have increased our full year 2026 adjusted earnings guidance by $0.25 to at least $5.25 per share.”

“Medicaid is expected to produce a 1.2% pre-tax margin in 2026, or approximately $5.75 per share.”

“Looking forward, we plan to again reduce our footprint and volumes in 2027 to minimize our exposure to this segment.”

“Excluding the 2026 losses from our Florida CMS contract and MAPD product, the 2026 earnings power is $7.75 per share.”

“Our 2026 EPS guidance of at least $5.25 includes $2.50 of losses in our segments that we expect will not recur in 2027.”

“In the second half, ex Florida KidCare, Medicaid is positioned to produce a 1.9, nearly a 2% pre-tax margin in the second half.”

“That's not in our projection to the $25 margin, the 6% G&A ratio, it is upside to that.”

“The market needs 300 basis points, and some of that may be a challenge for the market getting all 300 basis points.”

“Just a reminder, on our Medicare segment for the full year, we are projecting $6 billion of revenue, $5 billion is duals.”

“At its simplest, the $1.50, about a 1/3 of it, $0.50, is G&A we're carrying in the Q3 before we get the revenue.”